Details

Autor(en) / Beteiligte

• Stellacci, Emilia
• Steindl, Katharina
• Joset, Pascal
• Mercurio, Laura
• Anselmi, Massimiliano
• Cecchetti, Serena
• Gogoll, Laura
• Zweier, Markus
• Hackenberg, Annette
• Bocchinfuso, Gianfranco
• Stella, Lorenzo
• Tartaglia, Marco
• Rauch, Anita

Titel

Clinical and functional characterization of two novel ZBTB20 mutations causing Primrose syndrome

Ist Teil von

• Human mutation, 2018-07, Vol.39 (7), p.959-964

Ort / Verlag

United States: Hindawi Limited

Erscheinungsjahr

2018

Quelle

Wiley Online Library All Journals

Beschreibungen/Notizen

• Primrose syndrome (PS) is a rare disorder characterized by macrocephaly, tall stature, intellectual disability, autistic traits, and disturbances of glucose metabolism with insulin‐resistant diabetes and distal muscle wasting occurring in adulthood. The disorder is caused by functional dysregulation of ZBTB20, a transcriptional repressor controlling energetic metabolism and developmental programs. ZBTB20 maps in a genomic region that is deleted in the 3q13.31 microdeletion syndrome, which explains the clinical overlap between the two disorders. A narrow spectrum of amino acid substitutions in a restricted region of ZBTB20 encompassing the first and second zinc‐finger motifs have been reported thus far. Here, we characterize clinically and functionally the first truncating mutation [(c.1024delC; p.(Gln342Serfs*42)] and a missense change affecting the third zinc‐finger motif of the protein [(c.1931C > T; p.(Thr644Ile)]. Our data document that both mutations have dominant negative impact on wild‐type ZBTB20, providing further evidence of the specific behavior of PS‐causing mutations on ZBTB20 function. Primrose syndrome is a rare disorder characterized by macrocephaly, tall stature, intellectual disability, autistic traits, and disturbances of glucose metabolism with insulin‐resistant diabetes and distal muscle wasting occurring in adulthood. The disorder is caused by functional dysregulation of ZBTB20, a transcriptional repressor controlling energetic metabolism and developmental programs. Here, we characterize clinically and functionally the first truncating mutation [(c.1024delC; p.(Gln342Serfs*42)] and missense change affecting the third zinc‐finger motif of the protein [(c.1931C>T; p.(Thr644Ile)], providing evidence of a dominant negative role of both mutations.